Active03779957Private limited companyReading

MEDICINES EVALUATION UNIT LIMITED

Significant control: Iqvia Ltd. (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Medicines Evaluation Unit Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Medicines Evaluation Unit Limited sell?

Registered activity: Other research and experimental development on natural sciences and engineering (SIC 72190). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

MEDICINES EVALUATION UNIT LIMITED is an active private limited company (company number 03779957) incorporated on 28 May 1999, registered in Reading. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest medium accounts cover the period ending 31 March 2025, showing net assets of £38.30m and cash of £33.22m, with 160 employees on average. Turnover was £18.19m and profit for the year £5.34m. Net assets rose 13% on the prior period (£34.02m).

Peer position · net assets

By net assets it sits in the top quarter of 77 comparable companies in Reading (median £6,810, upper quartile £93k).

02

Ownership and control

1 active · 1 other
  • Iqvia Ltd.
    corporate entity, England · since 13 June 2025
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • North West Lung Research Centre Charity
    corporate entity · since 6 April 2016 · ceased 13 June 2025
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
28 May 199927 yrs ago
Next accounts due
31 December 2026in 65 days
Confirmation statement due
11 June 2027in 227 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72190
Other research and experimental development on natural sciences and engineering
Accounts type
Medium
Size band
MediumCompanies Act thresholds
05

Financials

3 periods on record · latest ending 31 March 2025
Net assets
£38.30m
+13%vs Mar 2024
Cash at bank
£33.22m
+70%vs Mar 2024
Turnover
£18.19m
No changevs Mar 2024
Employees
160
+7%vs Mar 2024
Net assets
£38.30m
Cash at bank
£33.22m
Turnover
£18.19m
Profit for the year
£5.34m
Average employees
160
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 March 2025£38.30m£33.22m£4.59m—£18.19m£5.34m160
31 March 2024£34.02m£19.50m£6.74m—£18.17m£7.36m149
31 March 2023———————
Net margin29.4%Profit for the year ÷ turnover
Cash per employee£208kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £38,296,895 at 31 March 2025
  • Net assets up 10% or more on the prior period+12.6% vs prior period
  • Cash at bank of £50,000 or moreCash £33,216,149
  • Three or more accounting periods on record3 periods on record
  • Incorporated five or more years agoIncorporated 28 May 1999

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 227 days
  2. Next accounts duein 65 days
  3. Accounts period endNet assets £38.30m · medium accounts
  4. Accounts period endNet assets £34.02m · medium accounts
  5. Accounts period end
  6. Incorporated
08

Similar companies in Reading

Same activity (other research and experimental development on natural sciences and engineering), closest in incorporation date
09

Reminders for MEDICINES EVALUATION UNIT LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown. Contact us about this company.